Söndag 22 December | 07:52:42 Europe / Stockholm

Kalender

Tid*
2024-12-20 - Kvartalsrapport 2024-Q3
2024-12-16 - 15-6 2024
2024-08-22 - Kvartalsrapport 2024-Q2
2024-08-14 - Extra Bolagsstämma 2024
2024-05-29 - X-dag ordinarie utdelning CIRCA 0.00 NOK
2024-05-28 - Årsstämma
2024-05-15 - Kvartalsrapport 2024-Q1
2024-02-15 - Bokslutskommuniké 2023
2023-11-09 - Kvartalsrapport 2023-Q3
2023-08-17 - Kvartalsrapport 2023-Q2
2023-05-26 - X-dag ordinarie utdelning CIRCA 0.00 NOK
2023-05-25 - Årsstämma
2023-05-11 - Kvartalsrapport 2023-Q1
2023-02-16 - Bokslutskommuniké 2022
2022-11-17 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-06-03 - X-dag ordinarie utdelning CIRCA 0.00 NOK
2022-06-02 - Årsstämma
2022-05-24 - Kvartalsrapport 2022-Q1
2022-03-02 - Bokslutskommuniké 2021
2021-11-25 - Kvartalsrapport 2021-Q3
2021-08-26 - Kvartalsrapport 2021-Q2
2021-06-17 - X-dag ordinarie utdelning CIRCA 0.00 NOK
2021-06-16 - Årsstämma
2021-05-27 - Kvartalsrapport 2021-Q1
2021-03-02 - Bokslutskommuniké 2020

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorHälsovård
IndustriBioteknik
Circa Group är verksamma inom bioteknik. Bolaget är en utvecklare av biokemikalier som vidare används för omvandling av avfallsmassa till diverse biokemiskt material. Tekniken används inom energisektorn vid olika produktionsprocesser. Bolaget grundades under 2006 och innehar störst verksamhet runtom den europeiska marknaden. Circa Group har sitt huvudkontor i Oslo, Norge.
2024-05-15 07:00:00
OSLO, NORWAY - 15 MAY 2024 - Circa Group AS (stock symbol: CIRCA) announced its
first quarter results today. A webinar will be held at 08.30 CET (details
below).

Progress continues at the ReSoluteTM site including the civil works which started
in January 2024, and which are now 50% complete. A considerable amount of the
site's equipment is already on-site or is ready for shipment from suppliers.

The environmental permitting process continues, with the public consultation
expected to start in Q2. The expectation is that the environmental permit will
be received by the end of Q3 or early Q4 2024.

This quarter saw an increase in commercial announcements with a partnership with
Merck to supply CyreneTM, Circa's sustainable, bio-derived industrial solvent and
a second agreement with IXOM Operations Pty Ltd to develop the market for
CyreneTM in the ANZ region.

Q1 also saw the arrival of a new CEO. Bertel Karlstedt joined Circa and has a
primary focus on driving forward the ResoluteTM project and supporting the
fundraising for ReSoluteTM.

Circa Group AS CEO Bertel Karlstedt said, "As I come to the end of my first
quarter in office, I see the tremendous potential for Circa's products, both
CyreneTM and other LGO derivatives. As regulations tighten globally and
consumers' appetite for more sustainable products increases, we are well-placed
in our mission of Changing chemistry for good."

For further information, please access the complete Q1 report:
https://circa-group.com/stock-announcements

To join the Q1 results webinar please copy and paste this link into your web
browser:

https://teams.microsoft.com/l/meetup-join/19%3ameeting_YjNiMjIyNDAtYjM4Mi00MGQ0L
TkzYzgtZmQ2YzU0NzAwNjFl%40thread.v2/0?context=%7b%22Tid%22%3a%227fe83212-6533-49
bf-96c7-1c50525cb252%22%2c%22Oid%22%3a%22b5d8e996-8850-4133-9fce-bf140a9a7209%22
%7d


About Circa
Established in 2006, Circa Group converts sustainable, non-food biomass into
advanced bio-based chemicals with its proprietary FuracellTM process. Its
developing product portfolio includes flavours, biopolymers, and bio-solvents
including CyreneTM. By creating renewable chemicals from cellulose, Circa is
extracting value from non-food biomass and addressing a gap in the market by
providing bio-based, less carbon intensive alternatives, contributing to a more
circular economy.
https://circa-group.com


Investor Contact
Tone Leivestad
Chief Financial Officer
Circa Group AS
tone.leivestad@circa-group.com
Tel: +47 406 39 455

Media Contact
Kathryn Sheridan
Sustainability Consult
ks@sustainabilityconsult.com